ONYIA JUDE (Chief Scientific Officer) sold 76.6% of their position (59.82K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $7.80M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/11/2025ACC: 0000914475-25-000151
Officer· Chief Scientific Officer
Since Nov 2021
-59.82K
Net shares
Net seller
$7.80M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
59.82K acquired · 119.64K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+59.82K
Price / share
$84.74
Trade value
$5.07M
% of position
327.1%
7/9/2025
18.29K→78.11K
Common Stock
Direct
Shares
−59.82K
Price / share
$130.46
Trade value
$7.80M
% of position
76.6%
7/9/2025
78.11K→18.29K
Total
Net shares
+0.00
Net value
-$2.73M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2025 | M · Option Exercise | +59.82K | $84.74 | $5.07M | 327.1% | 18.29K | 78.11K |
| Common Stock Direct | 7/9/2025 | S · Sale | −59.82K | $130.46 | $7.80M | 76.6% | 78.11K | 18.29K |
| Total | +0.00 | -$2.73M | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
59.82K shares
Shares
−59.82K
Strike price
84.74
Held after
35.27K
Exercisable
—
7/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock59.82K shares | 7/9/2025 | M · Option Exercise | −59.82K | 84.74 | — | 35.27K |